Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents
1996

Enhancing Lung Cancer Cell Sensitivity to Interferon

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): I Goto, Y Yamamoto-Yamaguchi, Y Honma

Primary Institution: Saitama Cancer Center

Hypothesis

Can differentiation-inducing agents enhance the sensitivity of lung adenocarcinoma cells to interferon alpha?

Conclusion

Differentiation inducers like DMSO significantly enhance the sensitivity of lung adenocarcinoma cells to interferon alpha, leading to greater growth inhibition.

Supporting Evidence

  • Differentiation inducers like DMSO increased the sensitivity of PC9 cells to interferon alpha by 170 times.
  • Combined treatment with DMSO and interferon alpha significantly inhibited tumor growth in xenograft models.
  • Alkaline phosphatase activity, a marker for cell maturation, was significantly induced by the combination treatment.

Takeaway

Some special chemicals can help lung cancer cells respond better to a medicine called interferon, making it more effective at stopping the cancer from growing.

Methodology

The study involved treating lung adenocarcinoma cell lines with differentiation inducers and measuring their sensitivity to interferon alpha using various assays.

Limitations

The study primarily focused on in vitro and xenograft models, which may not fully represent human responses.

Participant Demographics

The study used human lung adenocarcinoma cell lines derived from various types of lung cancer.

Statistical Information

P-Value

<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication